TP53 codon 72 polymorphism and glioma risk: A meta-analysis

  • Authors:
    • Minghan Shi
    • Ruishan Huang
    • Chunying Pei
    • Xiuzhi  Jia
    • Chuanlu Jiang
    • Huan Ren
  • View Affiliations

  • Published online on: December 12, 2011     https://doi.org/10.3892/ol.2011.521
  • Pages: 599-606
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

TP53 codon 72 polymorphism has been reported to affect regulatory networks central to glioma development. Although a number of published studies noted the association between TP53 codon 72 polymorphism and glioma risk, their conclusions were inconsistent. A meta-analysis was used to assess the possible association between TP53 codon 72 polymorphism and glioma risk. The PubMed databases were searched, relevant articles were identified and data were retrieved based on the inclusion criteria. The odds ratio (OR) and 95% confidence interval (95% CI) were determined on the pooled dataset. We retrieved eight different studies including 2,260 glioma cases and 3,506 controls. However, no association was found between the TP53 codon 72 polymorphism and glioma risk regarding the comparison between glioma cases and the controls. By further stratification based on criteria such as tumor grade, and the geographical location of the patients and the relevant controls, we found a significant association in the subgroup of patients with high-grade glioma in Europeans compared to controls in two models of TP53 codon 72 polymorphism, which include the dominant model [C/C + G/C vs. G/G: OR=1.35, 95% CI (1.14, 1.59), P=0.0005, Ph=0.13] and the additive model [C allele vs. G allele: OR=1.16, 95% CI (1.02, 1.33), P=0.03, Ph=0.37]. Our analysis suggests that TP53 codon 72 polymorphism is associated with an increased risk of high-grade glioma development in Europeans.
View Figures
View References

Related Articles

Journal Cover

March 2012
Volume 3 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shi M, Huang R, Pei C, Jia X, Jiang C and Ren H: TP53 codon 72 polymorphism and glioma risk: A meta-analysis. Oncol Lett 3: 599-606, 2012
APA
Shi, M., Huang, R., Pei, C., Jia, X., Jiang, C., & Ren, H. (2012). TP53 codon 72 polymorphism and glioma risk: A meta-analysis. Oncology Letters, 3, 599-606. https://doi.org/10.3892/ol.2011.521
MLA
Shi, M., Huang, R., Pei, C., Jia, X., Jiang, C., Ren, H."TP53 codon 72 polymorphism and glioma risk: A meta-analysis". Oncology Letters 3.3 (2012): 599-606.
Chicago
Shi, M., Huang, R., Pei, C., Jia, X., Jiang, C., Ren, H."TP53 codon 72 polymorphism and glioma risk: A meta-analysis". Oncology Letters 3, no. 3 (2012): 599-606. https://doi.org/10.3892/ol.2011.521